SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-052534
Filing Date
2021-04-20
Accepted
2021-04-20 16:16:17
Documents
6
Period of Report
2021-04-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm212624d1_pre14a.htm PRE 14A 576428
2 GRAPHIC tm212624d1_pre14aimg001.jpg GRAPHIC 1648
3 GRAPHIC tm212624d1_pre14aimg002.jpg GRAPHIC 1650
4 GRAPHIC tm212624d1_pre14aimg003.gif GRAPHIC 3682
5 GRAPHIC tm212624d1_pre14aimg004.jpg GRAPHIC 295001
6 GRAPHIC tm212624d1_pre14aimg005.jpg GRAPHIC 171261
  Complete submission text file 0001104659-21-052534.txt   1230014
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36672 | Film No.: 21838031
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences